Research Projects & Grants

• A pilot randomized clinical trial of base-in prism spectacles for intermittent Exotropia, Role: PI, Status: Completed

Federal

• A randomized clinical trial of overminus spectacle therapy for intermittent exotropia (IXT5), Role: PI, Jaeb Center for Health Research, (05/2022 - 05/2023) Status: Completed
• Amblyopia treatment study (ATS20) binocular dig rush game treatment for amblyopia, Role: PI, Jaeb Center for Health Research, (06/2020 - 06/2021) Status: Completed
• Amblyopia Treatment Study ATS20 Binocular Dig Rush Game Treatment for Amblyopia, Role: Principal Investigator, Jaeb Center for Health Research, (09/2017 - 12/2023) Status: Awarded
• Intermittent Exotropia Study 5 (IXT5) A Randomized Clinical Trial of Overminus Spectable Therapy for Intermittent Exotropia, Role: Principal Investigator, Jaeb Center for Health Research, (09/2017 - 12/2023) Status: Awarded

For Profit Organization

• A phase 2/3, randomized, double-masked, sham-controlled trial of QPI-1007 delivered by single or multi-dose intravitreal injection(s) to subjects with acute nonarteritic anterior ischemic optic neuropathy (NAION), Role: Investigator, Quark Pharmaceuticals, (01/2019 - 01/2020) Status: Completed
• The efficacy and safety of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension, Role: Investigator, Allergan Inc., (01/2019 - 01/2020) Status: Completed

Internal

• Pediatric Idiopathic lntracranial Hypertension, Role: Investigator, LLU Dept. of Neurosurgery, (07/2024) Status: Approved
• Visual Outcomes in Patients Treated with Acetazolamide for Papilledema Secondary to Intracranial Mass Effect, Role: PI, LLU Dept. of Ophthalmology, (01/2024) Status: Approved
• The incidence of dry eye syndrome in patients with pituitary tumors with and without transsphenoidal hypophysectomy, Role: PI, LLU Dept. of Ophthalmology, (07/2019) Status: Approved